UniProt D0PY27
D0PY27
D0PY27 (UniProt D0PY27): 14 experimental structures on GenesisL1. Binding sites, pockets, druggability and 3D structures in GL1X.
- UniProt
- D0PY27
- Experimental structures
- 14
- Predicted models
- 0
Structures
14 records of D0PY27 in the MolNFT archive: 14 experimental, 0 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 3PHE | HCV NS5B with a bound quinolone inhibitor | x-ray diffraction | A, B, C, D | — | — |
| 3PHE | HCV NS5B with a bound quinolone inhibitor | x-ray diffraction | A, B, C, D | — | — |
| 3VQS | Crystal structure of HCV NS5B RNA polymerase with a novel piperazine inhibitor | x-ray diffraction | A, B, C, D | — | — |
| 3VQS | Crystal structure of HCV NS5B RNA polymerase with a novel piperazine inhibitor | x-ray diffraction | A, B, C, D | — | — |
| 4TXS | An Ligand-observed Mass Spectrometry-based Approach Integrated into the Fragment Based Lead… | x-ray diffraction | A, B, C, D | — | — |
| 4TXS | An ligand-observed mass spectrometry-based approach integrated into the fragment based lead… | x-ray diffraction | A, B, C, D | — | — |
| 4TY8 | An Ligand-observed Mass Spectrometry-based Approach Integrated into the Fragment Based Lead… | x-ray diffraction | A, B, C, D | — | — |
| 4TY8 | An ligand-observed mass spectrometry-based approach integrated into the fragment based lead… | x-ray diffraction | A, B, C, D | — | — |
| 4TY9 | An Ligand-observed Mass Spectrometry-based Approach Integrated into the Fragment Based Lead… | x-ray diffraction | A, B, C, D | — | — |
| 4TY9 | An ligand-observed mass spectrometry-based approach integrated into the fragment based lead… | x-ray diffraction | A, B, C, D | — | — |
| 4TYA | An Ligand-observed Mass Spectrometry-based Approach Integrated into the Fragment Based Lead… | x-ray diffraction | A, B, C, D | — | — |
| 4TYA | An ligand-observed mass spectrometry-based approach integrated into the fragment based lead… | x-ray diffraction | A, B, C, D | — | — |
| 4TYB | An Ligand-observed Mass Spectrometry-based Approach Integrated into the Fragment Based Lead… | x-ray diffraction | A, B, C, D | — | — |
| 4TYB | An ligand-observed mass spectrometry-based approach integrated into the fragment based lead… | x-ray diffraction | A, B, C, D | — | — |
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.